Skip to main content

Table 2 Cost-effectiveness, Reference-case

From: Cost-effectiveness and budget impact of the management of uncomplicated urinary tract infection by community pharmacists

Strategy

Mean Costs, $

Mean Effects, QALMs

Incremental Costs, $

Incremental Effects, QALMs

ICER†,

$/QALM gained

Community pharmacist-initiated

72.47

(49.74; 99.61)

0.75137

(0.50954; 0.92395)

–

–

–

Family physician-initiated

141.53

(96.11; 198.26)

0.75142

(0.50910; 0.92384)

69.06

(16.16; 129.67)

0.00005

(−0.00673; 0.00718)

1,381,200

Emergency physician-initiated

368.16

(227.21; 543.26)

0.75146

(0.51983; 0.92400)

–

–

Extended dominance

  1. †Sequential analysis